Serveur d'exploration sur la COVID en France

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic.

Identifieur interne : 000366 ( Main/Exploration ); précédent : 000365; suivant : 000367

Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic.

Auteurs : Benjamin Marchandot [France] ; Antonin Trimaille [France] ; Anais Curtiaud [France] ; Kensuke Matsushita [France] ; Laurence Jesel [France] ; Olivier Morel [France]

Source :

RBID : pubmed:32696172

Abstract

A common and potent consideration has recently entered the landscape of the novel coronavirus disease of 2019 (COVID-19): venous thromboembolism (VTE). COVID-19 has been associated to a distinctive related coagulopathy that shows unique characteristics. The research community has risen to the challenges posed by this « evolving COVID-19 coagulopathy » and has made unprecedented efforts to promptly address its distinct characteristics. In such difficult time, both national and international societies of thrombosis and hemostasis released prompt and timely responses to guide recognition and management of COVID-19-related coagulopathy. However, latest guidelines released by the international Society on Thrombosis and Haemostasis (ISTH) on May 27, 2020, followed the American College of Chest Physicians (CHEST) on June 2, 2020 showed some discrepancies regarding thromboprophylaxis use. In this forum article, we would like to offer an updated focus on thromboprophylaxis with current incidence of VTE in ICU and non-ICU patients according to recent published studies; highlight the main differences regarding ISTH and CHEST guidelines; summarize and describe which are the key ongoing RCTs testing different anticoagulation strategies in patients with COVID-19; and finally set a proposal for COVID-19 coagulopathy specific risk factors and dedicated trials.

DOI: 10.1007/s11239-020-02231-3
PubMed: 32696172
PubMed Central: PMC7372740


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic.</title>
<author>
<name sortKey="Marchandot, Benjamin" sort="Marchandot, Benjamin" uniqKey="Marchandot B" first="Benjamin" last="Marchandot">Benjamin Marchandot</name>
<affiliation wicri:level="3">
<nlm:affiliation>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Alsace (région administrative)</region>
<settlement type="city">Strasbourg</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Trimaille, Antonin" sort="Trimaille, Antonin" uniqKey="Trimaille A" first="Antonin" last="Trimaille">Antonin Trimaille</name>
<affiliation wicri:level="3">
<nlm:affiliation>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Alsace (région administrative)</region>
<settlement type="city">Strasbourg</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Curtiaud, Anais" sort="Curtiaud, Anais" uniqKey="Curtiaud A" first="Anais" last="Curtiaud">Anais Curtiaud</name>
<affiliation wicri:level="3">
<nlm:affiliation>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Alsace (région administrative)</region>
<settlement type="city">Strasbourg</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Matsushita, Kensuke" sort="Matsushita, Kensuke" uniqKey="Matsushita K" first="Kensuke" last="Matsushita">Kensuke Matsushita</name>
<affiliation wicri:level="3">
<nlm:affiliation>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Alsace (région administrative)</region>
<settlement type="city">Strasbourg</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, 67000, Strasbourg, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, 67000, Strasbourg</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Alsace (région administrative)</region>
<settlement type="city">Strasbourg</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jesel, Laurence" sort="Jesel, Laurence" uniqKey="Jesel L" first="Laurence" last="Jesel">Laurence Jesel</name>
<affiliation wicri:level="3">
<nlm:affiliation>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Alsace (région administrative)</region>
<settlement type="city">Strasbourg</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, 67000, Strasbourg, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, 67000, Strasbourg</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Alsace (région administrative)</region>
<settlement type="city">Strasbourg</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Morel, Olivier" sort="Morel, Olivier" uniqKey="Morel O" first="Olivier" last="Morel">Olivier Morel</name>
<affiliation wicri:level="3">
<nlm:affiliation>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg, France. olivier.morel@chru-strasbourg.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Alsace (région administrative)</region>
<settlement type="city">Strasbourg</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, 67000, Strasbourg, France. olivier.morel@chru-strasbourg.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, 67000, Strasbourg</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Alsace (région administrative)</region>
<settlement type="city">Strasbourg</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32696172</idno>
<idno type="pmid">32696172</idno>
<idno type="doi">10.1007/s11239-020-02231-3</idno>
<idno type="pmc">PMC7372740</idno>
<idno type="wicri:Area/Main/Corpus">000875</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000875</idno>
<idno type="wicri:Area/Main/Curation">000875</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000875</idno>
<idno type="wicri:Area/Main/Exploration">000875</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic.</title>
<author>
<name sortKey="Marchandot, Benjamin" sort="Marchandot, Benjamin" uniqKey="Marchandot B" first="Benjamin" last="Marchandot">Benjamin Marchandot</name>
<affiliation wicri:level="3">
<nlm:affiliation>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Alsace (région administrative)</region>
<settlement type="city">Strasbourg</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Trimaille, Antonin" sort="Trimaille, Antonin" uniqKey="Trimaille A" first="Antonin" last="Trimaille">Antonin Trimaille</name>
<affiliation wicri:level="3">
<nlm:affiliation>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Alsace (région administrative)</region>
<settlement type="city">Strasbourg</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Curtiaud, Anais" sort="Curtiaud, Anais" uniqKey="Curtiaud A" first="Anais" last="Curtiaud">Anais Curtiaud</name>
<affiliation wicri:level="3">
<nlm:affiliation>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Alsace (région administrative)</region>
<settlement type="city">Strasbourg</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Matsushita, Kensuke" sort="Matsushita, Kensuke" uniqKey="Matsushita K" first="Kensuke" last="Matsushita">Kensuke Matsushita</name>
<affiliation wicri:level="3">
<nlm:affiliation>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Alsace (région administrative)</region>
<settlement type="city">Strasbourg</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, 67000, Strasbourg, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, 67000, Strasbourg</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Alsace (région administrative)</region>
<settlement type="city">Strasbourg</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jesel, Laurence" sort="Jesel, Laurence" uniqKey="Jesel L" first="Laurence" last="Jesel">Laurence Jesel</name>
<affiliation wicri:level="3">
<nlm:affiliation>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Alsace (région administrative)</region>
<settlement type="city">Strasbourg</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, 67000, Strasbourg, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, 67000, Strasbourg</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Alsace (région administrative)</region>
<settlement type="city">Strasbourg</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Morel, Olivier" sort="Morel, Olivier" uniqKey="Morel O" first="Olivier" last="Morel">Olivier Morel</name>
<affiliation wicri:level="3">
<nlm:affiliation>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg, France. olivier.morel@chru-strasbourg.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Alsace (région administrative)</region>
<settlement type="city">Strasbourg</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, 67000, Strasbourg, France. olivier.morel@chru-strasbourg.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, 67000, Strasbourg</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Alsace (région administrative)</region>
<settlement type="city">Strasbourg</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of thrombosis and thrombolysis</title>
<idno type="eISSN">1573-742X</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">A common and potent consideration has recently entered the landscape of the novel coronavirus disease of 2019 (COVID-19): venous thromboembolism (VTE). COVID-19 has been associated to a distinctive related coagulopathy that shows unique characteristics. The research community has risen to the challenges posed by this « evolving COVID-19 coagulopathy » and has made unprecedented efforts to promptly address its distinct characteristics. In such difficult time, both national and international societies of thrombosis and hemostasis released prompt and timely responses to guide recognition and management of COVID-19-related coagulopathy. However, latest guidelines released by the international Society on Thrombosis and Haemostasis (ISTH) on May 27, 2020, followed the American College of Chest Physicians (CHEST) on June 2, 2020 showed some discrepancies regarding thromboprophylaxis use. In this forum article, we would like to offer an updated focus on thromboprophylaxis with current incidence of VTE in ICU and non-ICU patients according to recent published studies; highlight the main differences regarding ISTH and CHEST guidelines; summarize and describe which are the key ongoing RCTs testing different anticoagulation strategies in patients with COVID-19; and finally set a proposal for COVID-19 coagulopathy specific risk factors and dedicated trials.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="Publisher" Owner="NLM">
<PMID Version="1">32696172</PMID>
<DateRevised>
<Year>2020</Year>
<Month>09</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1573-742X</ISSN>
<JournalIssue CitedMedium="Internet">
<PubDate>
<Year>2020</Year>
<Month>Jul</Month>
<Day>21</Day>
</PubDate>
</JournalIssue>
<Title>Journal of thrombosis and thrombolysis</Title>
<ISOAbbreviation>J. Thromb. Thrombolysis</ISOAbbreviation>
</Journal>
<ArticleTitle>Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic.</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s11239-020-02231-3</ELocationID>
<Abstract>
<AbstractText>A common and potent consideration has recently entered the landscape of the novel coronavirus disease of 2019 (COVID-19): venous thromboembolism (VTE). COVID-19 has been associated to a distinctive related coagulopathy that shows unique characteristics. The research community has risen to the challenges posed by this « evolving COVID-19 coagulopathy » and has made unprecedented efforts to promptly address its distinct characteristics. In such difficult time, both national and international societies of thrombosis and hemostasis released prompt and timely responses to guide recognition and management of COVID-19-related coagulopathy. However, latest guidelines released by the international Society on Thrombosis and Haemostasis (ISTH) on May 27, 2020, followed the American College of Chest Physicians (CHEST) on June 2, 2020 showed some discrepancies regarding thromboprophylaxis use. In this forum article, we would like to offer an updated focus on thromboprophylaxis with current incidence of VTE in ICU and non-ICU patients according to recent published studies; highlight the main differences regarding ISTH and CHEST guidelines; summarize and describe which are the key ongoing RCTs testing different anticoagulation strategies in patients with COVID-19; and finally set a proposal for COVID-19 coagulopathy specific risk factors and dedicated trials.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Marchandot</LastName>
<ForeName>Benjamin</ForeName>
<Initials>B</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0001-7034-1466</Identifier>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Trimaille</LastName>
<ForeName>Antonin</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Curtiaud</LastName>
<ForeName>Anais</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Matsushita</LastName>
<ForeName>Kensuke</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, 67000, Strasbourg, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jesel</LastName>
<ForeName>Laurence</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, 67000, Strasbourg, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Morel</LastName>
<ForeName>Olivier</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l'Hôpital, 67000, Strasbourg, France. olivier.morel@chru-strasbourg.fr.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, 67000, Strasbourg, France. olivier.morel@chru-strasbourg.fr.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>07</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>J Thromb Thrombolysis</MedlineTA>
<NlmUniqueID>9502018</NlmUniqueID>
<ISSNLinking>0929-5305</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">Coronavirus</Keyword>
<Keyword MajorTopicYN="N">Guidelines</Keyword>
<Keyword MajorTopicYN="N">Thromboprophylaxis</Keyword>
<Keyword MajorTopicYN="N">Venous thromboembolism</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>7</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>7</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>7</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32696172</ArticleId>
<ArticleId IdType="doi">10.1007/s11239-020-02231-3</ArticleId>
<ArticleId IdType="pii">10.1007/s11239-020-02231-3</ArticleId>
<ArticleId IdType="pmc">PMC7372740</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Thromb Haemost. 2020 Jul;120(7):1004-1024</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32473596</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Thromb Res. 2020 Sep;193:166-169</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32707275</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Thromb Res. 2020 Aug;192:23-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32405101</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2004 Jul;114(1):104-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15232617</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Thromb Res. 2020 Sep;193:1-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32485437</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Haematol. 2020 Jun;7(6):e425</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32470428</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Crit Care Med. 2020 Sep;48(9):e783-e790</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32459672</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Heart Lung Transplant. 2020 May;39(5):405-407</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32362390</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2011 Apr 7;364(14):1305-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21417952</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thromb Haemost. 2020 Jun;18(6):1516-1517</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32294289</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thromb Haemost. 2020 Jun;18(6):1517-1519</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32294295</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circulation. 2020 Jul 14;142(2):181-183</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32412320</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Thromb Res. 2020 Aug;192:113-115</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32425261</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 May 2;395(10234):1417-1418</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32325026</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32109013</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Med. 2020 May 31;9(6):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32486469</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Crit Care Med. 1982 Jul;10(7):448-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7044682</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thromb Haemost. 2020 Jun;18(6):1421-1424</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32271988</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Heart J. 2020 Jul 1;41(32):3058-3068</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32656565</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Jul 9;383(2):120-128</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32437596</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thromb Haemost. 2020 Jul;18(7):1743-1746</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32320517</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thromb Thrombolysis. 2020 Jul;50(1):211-216</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32451823</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thromb Haemost. 2020 Apr;18(4):844-847</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32073213</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thromb Haemost. 2020 Aug;18(8):2075-2076</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32470213</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Rheumatol. 2020 Jul;2(7):e437-e445</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32835247</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thromb Haemost. 2020 Sep;18(9):2138-2144</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32881336</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Radiology. 2020 Sep;296(3):E186-E188</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32324103</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Heart Fail. 2020 Jun;22(6):1046-1047</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32463538</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thromb Haemost. 2020 May;18(5):1023-1026</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32338827</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circulation. 2020 Jul 14;142(2):114-128</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32421381</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Coll Cardiol. 2020 Jul 28;76(4):480-482</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32479784</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Intern Med. 2020 Aug 18;173(4):268-277</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32374815</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thromb Haemost. 2020 Jul;18(7):1559-1561</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32302453</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 1):1109-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10764298</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Intensive Care Med. 2020 Jun;46(6):1089-1098</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32367170</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Res Pract Thromb Haemost. 2020 Jun 30;4(5):842-847</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32685893</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Thromb Res. 2020 Jul;191:9-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32353746</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA Netw Open. 2020 May 1;3(5):e2010478</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32469410</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Virol. 2020 Jun;127:104362</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32305883</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Semin Thromb Hemost. 2010 Jun;36(4):367-77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20614389</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thromb Thrombolysis. 2020 Apr 3;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32246317</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thromb Haemost. 2020 Aug;18(8):1995-2002</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32369666</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thromb Haemost. 2020 Jul 6;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32633068</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Crit Care Resusc. 2020 Apr 15;22(2):95-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32294809</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chest. 2020 Sep;158(3):1143-1163</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32502594</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Vasc Surg Venous Lymphat Disord. 2019 May;7(3):317-324</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30477976</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Respir Med. 2020 Jun;8(6):e46-e47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32353251</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Thromb Res. 2020 Jul;191:145-147</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32291094</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32311448</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thromb Haemost. 2020 Aug;18(8):1859-1865</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32459046</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Pathol Lab Med. 2004 Feb;128(2):195-204</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14736283</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thromb Haemost. 2020 May;18(5):1094-1099</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32220112</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Res Pract Thromb Haemost. 2020 Jul 06;4(5):731-736</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32685880</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circulation. 2020 Jul 14;142(2):184-186</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32330083</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Haematol. 2020 May;7(5):e362-e363</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32278361</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Alsace (région administrative)</li>
<li>Grand Est</li>
</region>
<settlement>
<li>Strasbourg</li>
</settlement>
</list>
<tree>
<country name="France">
<region name="Grand Est">
<name sortKey="Marchandot, Benjamin" sort="Marchandot, Benjamin" uniqKey="Marchandot B" first="Benjamin" last="Marchandot">Benjamin Marchandot</name>
</region>
<name sortKey="Curtiaud, Anais" sort="Curtiaud, Anais" uniqKey="Curtiaud A" first="Anais" last="Curtiaud">Anais Curtiaud</name>
<name sortKey="Jesel, Laurence" sort="Jesel, Laurence" uniqKey="Jesel L" first="Laurence" last="Jesel">Laurence Jesel</name>
<name sortKey="Jesel, Laurence" sort="Jesel, Laurence" uniqKey="Jesel L" first="Laurence" last="Jesel">Laurence Jesel</name>
<name sortKey="Matsushita, Kensuke" sort="Matsushita, Kensuke" uniqKey="Matsushita K" first="Kensuke" last="Matsushita">Kensuke Matsushita</name>
<name sortKey="Matsushita, Kensuke" sort="Matsushita, Kensuke" uniqKey="Matsushita K" first="Kensuke" last="Matsushita">Kensuke Matsushita</name>
<name sortKey="Morel, Olivier" sort="Morel, Olivier" uniqKey="Morel O" first="Olivier" last="Morel">Olivier Morel</name>
<name sortKey="Morel, Olivier" sort="Morel, Olivier" uniqKey="Morel O" first="Olivier" last="Morel">Olivier Morel</name>
<name sortKey="Trimaille, Antonin" sort="Trimaille, Antonin" uniqKey="Trimaille A" first="Antonin" last="Trimaille">Antonin Trimaille</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000366 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000366 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32696172
   |texte=   Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32696172" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidFranceV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021